{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T06:13:16Z","timestamp":1793686396830,"version":"4.5.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["FONDECYT Regular N\u00ba 1210655"],"award-info":[{"award-number":["FONDECYT Regular N\u00ba 1210655"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["Programa Iniciativa Cient\u00edfica Milenio"],"award-info":[{"award-number":["Programa Iniciativa Cient\u00edfica Milenio"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["Chile \u2013 N\u00ba ICN2021_004"],"award-info":[{"award-number":["Chile \u2013 N\u00ba ICN2021_004"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s00392-023-02291-4","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T09:02:23Z","timestamp":1693472543000},"page":"246-259","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Cardiovascular events risk in patients with systemic autoimmune diseases: a prognostic systematic review and meta-analysis"],"prefix":"10.1007","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8264-0524","authenticated-orcid":false,"given":"Claudia","family":"Asenjo-Lobos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0589-6884","authenticated-orcid":false,"given":"Leticia","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7849-3883","authenticated-orcid":false,"given":"Juan Francisco","family":"Bulnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0043-1364","authenticated-orcid":false,"given":"Marta","family":"Roque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1869-2255","authenticated-orcid":false,"given":"Paula","family":"Mu\u00f1oz Venturelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7120-855X","authenticated-orcid":false,"given":"Gonzalo Mart\u00ednez","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,31]]},"reference":[{"issue":"20","key":"2291_CR1","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1016\/j.jacc.2019.10.009","volume":"74","author":"GA Mensah","year":"2019","unstructured":"Mensah GA, Roth GA, Fuster V (2019) The global burden of cardiovascular diseases and risk factors: 2020 and beyond. J Am Coll Cardiol 74(20):2529\u20132532. https:\/\/doi.org\/10.1016\/j.jacc.2019.10.009","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2291_CR2","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/s0025-7125(05)70219-4","volume":"84","author":"AI Brown","year":"2000","unstructured":"Brown AI, Garber AM (2000) A concise review of the cost-effectiveness of coronary heart disease prevention. Med Clin North Am 84(1):279\u2013297. https:\/\/doi.org\/10.1016\/s0025-7125(05)70219-4","journal-title":"Med Clin North Am"},{"issue":"6116","key":"2291_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1126\/science.1230719","volume":"339","author":"FK Swirski","year":"2013","unstructured":"Swirski FK, Nahrendorf M (2013) Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science 339(6116):161\u2013166. https:\/\/doi.org\/10.1126\/science.1230719","journal-title":"Science"},{"issue":"3","key":"2291_CR4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41569-018-0106-9","volume":"16","author":"AP Sage","year":"2019","unstructured":"Sage AP, Tsiantoulas D, Binder CJ, Mallat Z (2019) The role of B cells in atherosclerosis. Nat Rev Cardiol 16(3):180\u2013196. https:\/\/doi.org\/10.1038\/s41569-018-0106-9","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"2291_CR5","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nrneph.2017.51","volume":"13","author":"A Gistera","year":"2017","unstructured":"Gistera A, Hansson GK (2017) The immunology of atherosclerosis. Nat Rev Nephrol 13(6):368\u2013380. https:\/\/doi.org\/10.1038\/nrneph.2017.51","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"2291_CR6","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41569-019-0227-9","volume":"16","author":"GL Basatemur","year":"2019","unstructured":"Basatemur GL, Jorgensen HF, Clarke MCH, Bennett MR, Mallat Z (2019) Vascular smooth muscle cells in atherosclerosis. Nat Rev Cardiol 16(12):727\u2013744. https:\/\/doi.org\/10.1038\/s41569-019-0227-9","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"2291_CR7","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/emmm.201201717","volume":"5","author":"O Soehnlein","year":"2013","unstructured":"Soehnlein O, Drechsler M, Doring Y, Lievens D, Hartwig H, Kemmerich K, Ortega-Gomez A, Mandl M, Vijayan S, Projahn D, Garlichs CD, Koenen RR, Hristov M, Lutgens E, Zernecke A, Weber C (2013) Distinct functions of chemokine receptor axes in the atherogenic mobilization and recruitment of classical monocytes. EMBO Mol Med 5(3):471\u2013481. https:\/\/doi.org\/10.1002\/emmm.201201717","journal-title":"EMBO Mol Med"},{"key":"2291_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3502","author":"JL Silveira Rossi","year":"2021","unstructured":"Silveira Rossi JL, Barbalho SM, Reverete de Araujo R, Bechara MD, Sloan KP, Sloan LA (2021) Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors. Diabetes Metab Res Rev. https:\/\/doi.org\/10.1002\/dmrr.3502","journal-title":"Diabetes Metab Res Rev"},{"issue":"12","key":"2291_CR9","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1042\/CS20180306","volume":"132","author":"GR Geovanini","year":"2018","unstructured":"Geovanini GR, Libby P (2018) Atherosclerosis and inflammation: overview and updates. Clin Sci (Lond) 132(12):1243\u20131252. https:\/\/doi.org\/10.1042\/CS20180306","journal-title":"Clin Sci (Lond)"},{"issue":"12","key":"2291_CR10","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ, Group CT (2017) Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 377(12):1119\u20131131. https:\/\/doi.org\/10.1056\/NEJMoa1707914","journal-title":"N Engl J Med"},{"issue":"42","key":"2291_CR11","doi-asserted-by":"publisher","first-page":"4092","DOI":"10.1093\/eurheartj\/ehaa659","volume":"41","author":"N Bouabdallaoui","year":"2020","unstructured":"Bouabdallaoui N, Tardif JC, Waters DD, Pinto FJ, Maggioni AP, Diaz R, Berry C, Koenig W, Lopez-Sendon J, Gamra H, Kiwan GS, Blondeau L, Orfanos A, Ibrahim R, Gregoire JC, Dube MP, Samuel M, Morel O, Lim P, Bertrand OF, Kouz S, Guertin MC, L\u2019Allier PL, Roubille F (2020) Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the colchicine cardiovascular outcomes trial (COLCOT). Eur Heart J 41(42):4092\u20134099. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa659","journal-title":"Eur Heart J"},{"issue":"20","key":"2291_CR12","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1161\/CIRCULATIONAHA.120.050771","volume":"142","author":"DC Tong","year":"2020","unstructured":"Tong DC, Quinn S, Nasis A, Hiew C, Roberts-Thomson P, Adams H, Sriamareswaran R, Htun NM, Wilson W, Stub D, van Gaal W, Howes L, Collins N, Yong A, Bhindi R, Whitbourn R, Lee A, Hengel C, Asrress K, Freeman M, Amerena J, Wilson A, Layland J (2020) Colchicine in patients with acute coronary syndrome: the Australian COPS randomized clinical trial. Circulation 142(20):1890\u20131900. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.050771","journal-title":"Circulation"},{"issue":"19","key":"2291_CR13","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","volume":"383","author":"SM Nidorf","year":"2020","unstructured":"Nidorf SM, Fiolet ATL, Mosterd A, Eikelboom JW, Schut A, Opstal TSJ, The SHK, Xu XF, Ireland MA, Lenderink T, Latchem D, Hoogslag P, Jerzewski A, Nierop P, Whelan A, Hendriks R, Swart H, Schaap J, Kuijper AFM, van Hessen MWJ, Saklani P, Tan I, Thompson AG, Morton A, Judkins C, Bax WA, Dirksen M, Alings M, Hankey GJ, Budgeon CA, Tijssen JGP, Cornel JH, Thompson PL, LoDoCo2 Trial I (2020) Colchicine in patients with chronic coronary disease. N Engl J Med 383(19):1838\u20131847. https:\/\/doi.org\/10.1056\/NEJMoa2021372","journal-title":"N Engl J Med"},{"issue":"3","key":"2291_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1006\/clin.1997.4412","volume":"84","author":"DL Jacobson","year":"1997","unstructured":"Jacobson DL, Gange SJ, Rose NR, Graham NM (1997) Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 84(3):223\u2013243. https:\/\/doi.org\/10.1006\/clin.1997.4412","journal-title":"Clin Immunol Immunopathol"},{"issue":"3","key":"2291_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/s1568-9972(03)00006-5","volume":"2","author":"GS Cooper","year":"2003","unstructured":"Cooper GS, Stroehla BC (2003) The epidemiology of autoimmune diseases. Autoimmun Rev 2(3):119\u2013125. https:\/\/doi.org\/10.1016\/s1568-9972(03)00006-5","journal-title":"Autoimmun Rev"},{"key":"2291_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001470","author":"P Santos-Moreno","year":"2021","unstructured":"Santos-Moreno P, Burgos-Angulo G, Martinez-Ceballos MA, Pizano A, Echeverri D, Bautista-Nino PK, Roks AJM, Rojas-Villarraga A (2021) Inflammaging as a link between autoimmunity and cardiovascular disease: the case of rheumatoid arthritis. RMD Open. https:\/\/doi.org\/10.1136\/rmdopen-2020-001470","journal-title":"RMD Open"},{"issue":"7347","key":"2291_CR17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature10146","volume":"473","author":"P Libby","year":"2011","unstructured":"Libby P, Ridker PM, Hansson GK (2011) Progress and challenges in translating the biology of atherosclerosis. Nature 473(7347):317\u2013325. https:\/\/doi.org\/10.1038\/nature10146","journal-title":"Nature"},{"issue":"7","key":"2291_CR18","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1172\/JCI97950","volume":"128","author":"C Kasikara","year":"2018","unstructured":"Kasikara C, Doran AC, Cai B, Tabas I (2018) The role of non-resolving inflammation in atherosclerosis. J Clin Invest 128(7):2713\u20132723. https:\/\/doi.org\/10.1172\/JCI97950","journal-title":"J Clin Invest"},{"issue":"11","key":"2291_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11883-020-00883-3","volume":"22","author":"ON Ajala","year":"2020","unstructured":"Ajala ON, Everett BM (2020) Targeting inflammation to reduce residual cardiovascular risk. Curr Atheroscler Rep 22(11):66. https:\/\/doi.org\/10.1007\/s11883-020-00883-3","journal-title":"Curr Atheroscler Rep"},{"issue":"1","key":"2291_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/clinchem\/hvaa275","volume":"67","author":"P Libby","year":"2021","unstructured":"Libby P (2021) Inflammation in Atherosclerosis-No Longer a Theory. Clin Chem 67(1):131\u2013142. https:\/\/doi.org\/10.1093\/clinchem\/hvaa275","journal-title":"Clin Chem"},{"issue":"6","key":"2291_CR21","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.autrev.2019.01.002","volume":"18","author":"RG Misse","year":"2019","unstructured":"Misse RG, Borges IBP, Shinjo SK (2019) Endothelial function features and properties of large vessel behavior in systemic autoimmune diseases: a cross-talk among cardiovascular disease risk factors. Autoimmun Rev 18(6):637\u2013638. https:\/\/doi.org\/10.1016\/j.autrev.2019.01.002","journal-title":"Autoimmun Rev"},{"issue":"5","key":"2291_CR22","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jaad.2006.08.040","volume":"55","author":"AL Neimann","year":"2006","unstructured":"Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM (2006) Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 55(5):829\u2013835. https:\/\/doi.org\/10.1016\/j.jaad.2006.08.040","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"2291_CR23","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1136\/heartjnl-2015-307838","volume":"102","author":"R Agca","year":"2016","unstructured":"Agca R, Heslinga SC, van Halm VP, Nurmohamed MT (2016) Atherosclerotic cardiovascular disease in patients with chronic inflammatory joint disorders. Heart 102(10):790\u2013795. https:\/\/doi.org\/10.1136\/heartjnl-2015-307838","journal-title":"Heart"},{"issue":"1","key":"2291_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jcct.2021.06.003","volume":"16","author":"NH Patel","year":"2022","unstructured":"Patel NH, Dey AK, Sorokin AV, Teklu M, Petrole R, Zhou W, Mehta NN (2022) Chronic inflammatory diseases and coronary heart disease: Insights from cardiovascular CT. J Cardiovasc Comput Tomogr 16(1):7\u201318. https:\/\/doi.org\/10.1016\/j.jcct.2021.06.003","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"15","key":"2291_CR25","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283(15):2008\u20132012. https:\/\/doi.org\/10.1001\/jama.283.15.2008","journal-title":"JAMA"},{"issue":"4","key":"2291_CR26","doi-asserted-by":"publisher","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","volume":"158","author":"JA Hayden","year":"2013","unstructured":"Hayden JA, van der Windt DA, Cartwright JL, Cote P, Bombardier C (2013) Assessing bias in studies of prognostic factors. Ann Intern Med 158(4):280\u2013286. https:\/\/doi.org\/10.7326\/0003-4819-158-4-201302190-00009","journal-title":"Ann Intern Med"},{"key":"2291_CR27","doi-asserted-by":"publisher","first-page":"4597","DOI":"10.1136\/bmj.k4597","volume":"364","author":"RD Riley","year":"2019","unstructured":"Riley RD, Moons KGM, Snell KIE, Ensor J, Hooft L, Altman DG, Hayden J, Collins GS, Debray TPA (2019) A guide to systematic review and meta-analysis of prognostic factor studies. BMJ 364:4597. https:\/\/doi.org\/10.1136\/bmj.k4597","journal-title":"BMJ"},{"issue":"10","key":"2291_CR28","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/art.24537","volume":"61","author":"AE Hak","year":"2009","unstructured":"Hak AE, Karlson EW, Feskanich D, Stampfer MJ, Costenbader KH (2009) Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses\u2019 health study. Arthritis Rheum 61(10):1396\u20131402. https:\/\/doi.org\/10.1002\/art.24537","journal-title":"Arthritis Rheum"},{"issue":"9","key":"2291_CR29","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1161\/01.cir.0000054612.26458.b2","volume":"107","author":"DH Solomon","year":"2003","unstructured":"Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, Stampfer MJ, Curhan GC (2003) Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 107(9):1303\u20131307. https:\/\/doi.org\/10.1161\/01.cir.0000054612.26458.b2","journal-title":"Circulation"},{"issue":"6","key":"2291_CR30","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/j.1365-2796.2010.02260.x","volume":"268","author":"ME Holmqvist","year":"2010","unstructured":"Holmqvist ME, Wedren S, Jacobsson LT, Klareskog L, Nyberg F, Rantapaa-Dahlqvist S, Alfredsson L, Askling J (2010) Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006. J Intern Med 268(6):578\u2013585. https:\/\/doi.org\/10.1111\/j.1365-2796.2010.02260.x","journal-title":"J Intern Med"},{"issue":"12","key":"2291_CR31","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1136\/ard.2005.050377","volume":"65","author":"DH Solomon","year":"2006","unstructured":"Solomon DH, Goodson NJ, Katz JN, Weinblatt ME, Avorn J, Setoguchi S, Canning C, Schneeweiss S (2006) Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis 65(12):1608\u20131612. https:\/\/doi.org\/10.1136\/ard.2005.050377","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"2291_CR32","first-page":"1196","volume":"30","author":"DJ Watson","year":"2003","unstructured":"Watson DJ, Rhodes T, Guess HA (2003) All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK general practice research database. J Rheumatol 30(6):1196\u20131202","journal-title":"J Rheumatol"},{"issue":"2","key":"2291_CR33","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1365-2796.2010.02310.x","volume":"270","author":"O Ahlehoff","year":"2011","unstructured":"Ahlehoff O, Gislason GH, Charlot M, Jorgensen CH, Lindhardsen J, Olesen JB, Abildstrom SZ, Skov L, Torp-Pedersen C, Hansen PR (2011) Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. J Intern Med 270(2):147\u2013157. https:\/\/doi.org\/10.1111\/j.1365-2796.2010.02310.x","journal-title":"J Intern Med"},{"issue":"5","key":"2291_CR34","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/jid.2015.8","volume":"135","author":"M Koch","year":"2015","unstructured":"Koch M, Baurecht H, Ried JS, Rodriguez E, Schlesinger S, Volks N, Gieger C, Ruckert IM, Heinrich L, Willenborg C, Smith C, Peters A, Thorand B, Koenig W, Lamina C, Jansen H, Kronenberg F, Seissler J, Thiery J, Rathmann W, Schunkert H, Erdmann J, Barker J, Nair RP, Tsoi LC, Elder JT, Mrowietz U, Weichenthal M, Mucha S, Schreiber S, Franke A, Schmitt J, Lieb W, Weidinger S (2015) Psoriasis and cardiometabolic traits: modest association but distinct genetic architectures. J Invest Dermatol 135(5):1283\u20131293. https:\/\/doi.org\/10.1038\/jid.2015.8","journal-title":"J Invest Dermatol"},{"issue":"12","key":"2291_CR35","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-%23","volume":"44","author":"ID del Rincon","year":"2001","unstructured":"del Rincon ID, Williams K, Stern MP, Freeman GL, Escalante A (2001) High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 44(12):2737\u20132745. https:\/\/doi.org\/10.1002\/1529-0131(200112)44:12%3c2737::AID-ART460%3e3.0.CO;2-%23","journal-title":"Arthritis Rheum"},{"issue":"6","key":"2291_CR36","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1136\/ard.2010.143396","volume":"70","author":"J Lindhardsen","year":"2011","unstructured":"Lindhardsen J, Ahlehoff O, Gislason GH, Madsen OR, Olesen JB, Torp-Pedersen C, Hansen PR (2011) The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study. Ann Rheum Dis 70(6):929\u2013934. https:\/\/doi.org\/10.1136\/ard.2010.143396","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2291_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12915","volume":"48","author":"BB Logstrup","year":"2018","unstructured":"Logstrup BB, Ellingsen T, Pedersen AB, Kjaersgaard A, Botker HE, Maeng M (2018) Development of heart failure in patients with rheumatoid arthritis: a Danish population-based study. Eur J Clin Invest 48(5):e12915. https:\/\/doi.org\/10.1111\/eci.12915","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"2291_CR38","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/art.20853","volume":"52","author":"H Maradit-Kremers","year":"2005","unstructured":"Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ, Gabriel SE (2005) Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 52(2):402\u2013411. https:\/\/doi.org\/10.1002\/art.20853","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2291_CR39","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1136\/annrheumdis-2016-209315","volume":"76","author":"JK Eriksson","year":"2017","unstructured":"Eriksson JK, Jacobsson L, Bengtsson K, Askling J (2017) Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis? Ann Rheum Dis 76(2):364\u2013370. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209315","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2291_CR40","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13075-017-1315-z","volume":"19","author":"K Bengtsson","year":"2017","unstructured":"Bengtsson K, Forsblad-d\u2019Elia H, Lie E, Klingberg E, Dehlin M, Exarchou S, Lindstrom U, Askling J, Jacobsson LTH (2017) Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study. Arthritis Res Ther 19(1):102. https:\/\/doi.org\/10.1186\/s13075-017-1315-z","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"2291_CR41","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1161\/CIRCRESAHA.123.322791","volume":"132","author":"SK Mohanta","year":"2023","unstructured":"Mohanta SK, Yin C, Weber C, Godinho-Silva C, Veiga-Fernandes H, Xu QJ, Chang RB, Habenicht AJR (2023) Cardiovascular brain circuits. Circ Res 132(11):1546\u20131565. https:\/\/doi.org\/10.1161\/CIRCRESAHA.123.322791","journal-title":"Circ Res"},{"issue":"1","key":"2291_CR42","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0002-9343(84)90449-2","volume":"77","author":"SM Korbet","year":"1984","unstructured":"Korbet SM, Schwartz MM, Lewis EJ (1984) Immune complex deposition and coronary vasculitis in systemic lupus erythematosus. Report of two cases. Am J Med 77(1):141\u2013146. https:\/\/doi.org\/10.1016\/0002-9343(84)90449-2","journal-title":"Am J Med"},{"issue":"19","key":"2291_CR43","doi-asserted-by":"publisher","first-page":"4427","DOI":"10.3390\/jcm10194427","volume":"10","author":"AM Hedar","year":"2021","unstructured":"Hedar AM, Stradner MH, Roessler A, Goswami N (2021) Autoimmune rheumatic diseases and vascular function: the concept of autoimmune atherosclerosis. J Clin Med 10(19):4427. https:\/\/doi.org\/10.3390\/jcm10194427","journal-title":"J Clin Med"},{"issue":"7","key":"2291_CR44","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s10067-013-2237-z","volume":"32","author":"M Zhu","year":"2013","unstructured":"Zhu M, Mo H, Li D, Luo X, Zhang L (2013) Th17\/Treg imbalance induced by increased incidence of atherosclerosis in patients with systemic lupus erythematosus (SLE). Clin Rheumatol 32(7):1045\u20131052. https:\/\/doi.org\/10.1007\/s10067-013-2237-z","journal-title":"Clin Rheumatol"},{"key":"2291_CR45","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3389\/fphar.2017.00460","volume":"8","author":"P Li","year":"2017","unstructured":"Li P, Zheng Y, Chen X (2017) Drugs for autoimmune inflammatory diseases: from small molecule compounds to anti-TNF biologics. Front Pharmacol 8:460. https:\/\/doi.org\/10.3389\/fphar.2017.00460","journal-title":"Front Pharmacol"},{"issue":"3","key":"2291_CR46","first-page":"398","volume":"35","author":"G Kerekes","year":"2008","unstructured":"Kerekes G, Szekanecz Z, Der H, Sandor Z, Lakos G, Muszbek L, Csipo I, Sipka S, Seres I, Paragh G, Kappelmayer J, Szomjak E, Veres K, Szegedi G, Shoenfeld Y, Soltesz P (2008) Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. J Rheumatol 35(3):398\u2013406","journal-title":"J Rheumatol"},{"issue":"10","key":"2291_CR47","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1002\/art.41381","volume":"72","author":"H Westerlind","year":"2020","unstructured":"Westerlind H, Ronnelid J, Hansson M, Alfredsson L, Mathsson-Alm L, Serre G, Cornillet M, Holmdahl R, Jakobsson PJ, Skriner K, Klareskog L, Saevarsdottir S, Askling J (2020) Anti-citrullinated protein antibody specificities, rheumatoid factor isotypes, and incident cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheumatol 72(10):1658\u20131667. https:\/\/doi.org\/10.1002\/art.41381","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"2291_CR48","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1093\/rheumatology\/kep288","volume":"48","author":"M Pertovaara","year":"2009","unstructured":"Pertovaara M, Kahonen M, Juonala M, Laitinen T, Taittonen L, Lehtimaki T, Viikari JS, Raitakari OT, Hurme M (2009) Autoimmunity and atherosclerosis: the presence of antinuclear antibodies is associated with decreased carotid elasticity in young women. The cardiovascular risk in young Finns study. Rheumatology (Oxford) 48(12):1553\u20131556. https:\/\/doi.org\/10.1093\/rheumatology\/kep288","journal-title":"Rheumatology (Oxford)"},{"key":"2291_CR49","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/367359","volume":"2014","author":"J Amaya-Amaya","year":"2014","unstructured":"Amaya-Amaya J, Montoya-Sanchez L, Rojas-Villarraga A (2014) Cardiovascular involvement in autoimmune diseases. Biomed Res Int 2014:367359. https:\/\/doi.org\/10.1155\/2014\/367359","journal-title":"Biomed Res Int"},{"issue":"6","key":"2291_CR50","doi-asserted-by":"publisher","first-page":"566","DOI":"10.2174\/1570161118666200127142936","volume":"18","author":"F Atzeni","year":"2020","unstructured":"Atzeni F, Nucera V, Gerratana E, Fiorenza A, Gianturco L, Corda M, Sarzi-Puttini P (2020) Cardiovascular consequences of autoimmune rheumatic diseases. Curr Vasc Pharmacol 18(6):566\u2013579. https:\/\/doi.org\/10.2174\/1570161118666200127142936","journal-title":"Curr Vasc Pharmacol"},{"issue":"1","key":"2291_CR51","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s42358-019-0089-1","volume":"59","author":"MFB de Resende Guimaraes","year":"2019","unstructured":"de Resende Guimaraes MFB, Rodrigues CEM, Gomes KWP, Machado CJ, Brenol CV, Krampe SF, de Andrade NPB, Kakehasi AM (2019) High prevalence of obesity in rheumatoid arthritis patients: association with disease activity, hypertension, dyslipidemia and diabetes, a multi-center study. Adv Rheumatol 59(1):44. https:\/\/doi.org\/10.1186\/s42358-019-0089-1","journal-title":"Adv Rheumatol"},{"issue":"1","key":"2291_CR52","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","volume":"335","author":"AE Coutinho","year":"2011","unstructured":"Coutinho AE, Chapman KE (2011) The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol 335(1):2\u201313. https:\/\/doi.org\/10.1016\/j.mce.2010.04.005","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"2291_CR53","doi-asserted-by":"publisher","first-page":"379","DOI":"10.14740\/jocmr2122w","volume":"7","author":"A Durante","year":"2015","unstructured":"Durante A, Bronzato S (2015) The increased cardiovascular risk in patients affected by autoimmune diseases: review of the various manifestations. J Clin Med Res 7(6):379\u2013384. https:\/\/doi.org\/10.14740\/jocmr2122w","journal-title":"J Clin Med Res"},{"issue":"6","key":"2291_CR54","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1093\/rheumatology\/ket454","volume":"53","author":"LS Tam","year":"2014","unstructured":"Tam LS, Kitas GD, Gonzalez-Gay MA (2014) Can suppression of inflammation by anti-TNF prevent progression of subclinical atherosclerosis in inflammatory arthritis? Rheumatology (Oxford) 53(6):1108\u20131119. https:\/\/doi.org\/10.1093\/rheumatology\/ket454","journal-title":"Rheumatology (Oxford)"},{"issue":"6245","key":"2291_CR55","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1126\/science.aac7801","volume":"349","author":"M Nahrendorf","year":"2015","unstructured":"Nahrendorf M, Swirski FK (2015) Immunology. Neutrophil-macrophage communication in inflammation and atherosclerosis. Science 349(6245):237\u2013238. https:\/\/doi.org\/10.1126\/science.aac7801","journal-title":"Science"},{"key":"2291_CR56","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3389\/fmed.2018.00026","volume":"5","author":"F Atzeni","year":"2018","unstructured":"Atzeni F, Corda M, Gianturco L, Porcu M, Sarzi-Puttini P, Turiel M (2018) Cardiovascular imaging techniques in systemic rheumatic diseases. Front Med (Lausanne) 5:26. https:\/\/doi.org\/10.3389\/fmed.2018.00026","journal-title":"Front Med (Lausanne)"},{"issue":"7","key":"2291_CR57","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.autrev.2016.03.014","volume":"15","author":"Z Szekanecz","year":"2016","unstructured":"Szekanecz Z, Kerekes G, Vegh E, Kardos Z, Barath Z, Tamasi L, Shoenfeld Y (2016) Autoimmune atherosclerosis in 3D: How it develops, how to diagnose and what to do. Autoimmun Rev 15(7):756\u2013769. https:\/\/doi.org\/10.1016\/j.autrev.2016.03.014","journal-title":"Autoimmun Rev"},{"issue":"8","key":"2291_CR58","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/s41569-021-00583-8","volume":"18","author":"ED Michos","year":"2021","unstructured":"Michos ED, Van Spall HGC (2021) Increasing representation and diversity in cardiovascular clinical trial populations. Nat Rev Cardiol 18(8):537\u2013538. https:\/\/doi.org\/10.1038\/s41569-021-00583-8","journal-title":"Nat Rev Cardiol"},{"issue":"10354","key":"2291_CR59","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S0140-6736(22)01349-6","volume":"400","author":"N Conrad","year":"2022","unstructured":"Conrad N, Verbeke G, Molenberghs G, Goetschalckx L, Callender T, Cambridge G, Mason JC, Rahimi K, McMurray JJV, Verbakel JY (2022) Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK. Lancet 400(10354):733\u2013743. https:\/\/doi.org\/10.1016\/S0140-6736(22)01349-6","journal-title":"Lancet"},{"issue":"28","key":"2291_CR60","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1093\/eurheartj\/ehab115","volume":"42","author":"ATL Fiolet","year":"2021","unstructured":"Fiolet ATL, Opstal TSJ, Mosterd A, Eikelboom JW, Jolly SS, Keech AC, Kelly P, Tong DC, Layland J, Nidorf SM, Thompson PL, Budgeon C, Tijssen JGP, Cornel JH (2021) Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials. Eur Heart J 42(28):2765\u20132775. https:\/\/doi.org\/10.1093\/eurheartj\/ehab115","journal-title":"Eur Heart J"},{"issue":"30","key":"2291_CR61","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1093\/eurheartj\/ehw171","volume":"37","author":"O Kleveland","year":"2016","unstructured":"Kleveland O, Kunszt G, Bratlie M, Ueland T, Broch K, Holte E, Michelsen AE, Bendz B, Amundsen BH, Espevik T, Aakhus S, Damas JK, Aukrust P, Wiseth R, Gullestad L (2016) Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial. Eur Heart J 37(30):2406\u20132413. https:\/\/doi.org\/10.1093\/eurheartj\/ehw171","journal-title":"Eur Heart J"},{"issue":"8","key":"2291_CR62","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1056\/NEJMoa1809798","volume":"380","author":"PM Ridker","year":"2019","unstructured":"Ridker PM, Everett BM, Pradhan A, MacFadyen JG, Solomon DH, Zaharris E, Mam V, Hasan A, Rosenberg Y, Iturriaga E, Gupta M, Tsigoulis M, Verma S, Clearfield M, Libby P, Goldhaber SZ, Seagle R, Ofori C, Saklayen M, Butman S, Singh N, Le May M, Bertrand O, Johnston J, Paynter NP, Glynn RJ, Investigators C (2019) Low-dose methotrexate for the prevention of atherosclerotic events. N Engl J Med 380(8):752\u2013762. https:\/\/doi.org\/10.1056\/NEJMoa1809798","journal-title":"N Engl J Med"},{"issue":"3","key":"2291_CR63","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","volume":"74","author":"C Roubille","year":"2015","unstructured":"Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, Siu S, Kraft J, Lynde C, Pope J, Gulliver W, Keeling S, Dutz J, Bessette L, Bissonnette R, Haraoui B (2015) The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis 74(3):480\u2013489. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206624","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2291_CR64","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3899\/jrheum.200265","volume":"48","author":"G Ozen","year":"2021","unstructured":"Ozen G, Pedro S, Michaud K (2021) The risk of cardiovascular events associated with disease-modifying antirheumatic drugs in rheumatoid arthritis. J Rheumatol 48(5):648\u2013655. https:\/\/doi.org\/10.3899\/jrheum.200265","journal-title":"J Rheumatol"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02291-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-023-02291-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02291-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T17:05:26Z","timestamp":1707325526000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-023-02291-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,31]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["2291"],"URL":"https:\/\/doi.org\/10.1007\/s00392-023-02291-4","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,31]]},"assertion":[{"value":"27 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}